X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-18 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.02 | -10,000 | 2,174,662 | 0% | -$160,163 | ||||||
2024-03-25 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.01 | -10,000 | 2,184,662 | 0% | -$160,055 | ||||||
2024-03-11 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $15.24 | -30,000 | 2,194,662 | -1% | -$457,314 | ||||||
2024-02-27 | DAWN | Blackman Samuel C. | HEAD OF R, D | S - Sale | $16.11 | -20,000 | 2,224,662 | -1% | -$322,166 | ||||||
| D | 2024-02-16 | DAWN | Blackman Samuel C. | Head of Research, Developme | S - Sale+OE | $15.25 | -2,258 | 2,244,662 | 0% | -$34,430 | |||||
| D | 2023-11-16 | DAWN | Blackman Samuel C. | Head of Research, Developme | S - Sale+OE | $11.69 | -709 | 2,238,234 | 0% | -$8,288 | |||||
| D | 2023-08-17 | DAWN | Blackman Samuel C. | Head of Research, Developme | S - Sale+OE | $13.86 | -668 | 2,236,319 | 0% | -$9,258 | |||||
2023-06-05 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $16.00 | -1,229 | 2,234,363 | 0% | -$19,664 | ||||||
| D | 2023-05-16 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale+OE | $13.12 | -692 | 2,235,592 | 0% | -$9,081 | |||||
2023-03-10 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $18.05 | -10,000 | 2,233,660 | 0% | -$180,484 | ||||||
| D | 2023-02-16 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale+OE | $19.57 | -674 | 2,243,660 | 0% | -$13,192 | |||||
2023-02-10 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $20.07 | -10,000 | 2,241,710 | 0% | -$200,659 | ||||||
2023-01-10 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $22.86 | -10,000 | 2,250,148 | 0% | -$228,644 | ||||||
2022-12-01 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $21.45 | -10,000 | 2,260,148 | 0% | -$214,530 | ||||||
| D | 2022-11-16 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale+OE | $21.46 | -377 | 2,270,148 | 0% | -$8,090 | |||||
2022-11-01 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $20.01 | -10,000 | 2,269,338 | 0% | -$200,050 | ||||||
2022-10-03 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $19.99 | -10,000 | 2,279,338 | 0% | -$199,852 | ||||||
2022-09-01 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $23.25 | -10,000 | 2,289,338 | 0% | -$232,452 | ||||||
| D | 2022-08-16 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale+OE | $24.31 | -941 | 2,299,338 | 0% | -$22,876 | |||||
2022-08-01 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $16.88 | -10,000 | 2,296,718 | 0% | -$168,810 | ||||||
2022-07-01 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $18.72 | -10,000 | 2,306,718 | 0% | -$187,158 | ||||||
2022-06-15 | DAWN | Blackman Samuel C. | Chief Medical Officer | S - Sale | $16.26 | -50,000 | 2,316,718 | -2% | -$813,155 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |